Solventum posts Q3 loss, raises full‑year EPS guidance to $7.20‑$7.30
+1 new source since this summary was written
Solventum Corp reported third‑quarter 2026 revenue of $1.95 billion, down 7% year‑over‑year and 2.8% on an organic basis. Adjusted diluted earnings per share were $1.45, while GAAP EPS was a loss of $0.07. The company lifted its full‑year adjusted EPS outlook to $7.20‑$7.30 and expects organic sales growth toward the high end of its 2.5%‑3.0% range, citing completion of its ERP cutover and the 90%‑complete separation from 3M.
Why it matters
The raised EPS guidance signals higher profitability for the rest of 2026, which may support the stock price and affect analysts' target models (BTIG’s price‑target increase to $100 reflects this view). The guidance also implies continued margin expansion as the 3M separation progresses.
Key facts
- 1Q3 2026 sales were $1.95 billion, a 7% decline on a reported basis and a 2.8% decline organically. prnewswire.com
- 2Adjusted diluted EPS was $1.45, a 3.6% decrease year‑over‑year. prnewswire.com
- 3GAAP diluted EPS was a loss of $(0.07). prnewswire.com
- 4Operating cash flow was $177 million and free cash flow was $97 million. prnewswire.com
- 5Full‑year adjusted EPS guidance was raised to $7.20‑$7.30. prnewswire.com
- 6Full‑year organic sales growth outlook moved toward the high end of the 2.5%‑3.0% range. prnewswire.com
Summary written by AlphAI AI Desk from 12 of 12 sources. Not investment advice. Figures are as stated by the linked sources.